Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Adjuvant intraoperative photodynamic therapy in head and neck cancer.

Rigual NR, Shafirstein G, Frustino J, Seshadri M, Cooper M, Wilding G, Sullivan MA, Henderson B.

JAMA Otolaryngol Head Neck Surg. 2013 Jul;139(7):706-11. doi: 10.1001/jamaoto.2013.3387.

2.

Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity.

Rigual N, Shafirstein G, Cooper MT, Baumann H, Bellnier DA, Sunar U, Tracy EC, Rohrbach DJ, Wilding G, Tan W, Sullivan M, Merzianu M, Henderson BW.

Clin Cancer Res. 2013 Dec 1;19(23):6605-13. doi: 10.1158/1078-0432.CCR-13-1735. Epub 2013 Oct 2.

3.

Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus.

Nava HR, Allamaneni SS, Dougherty TJ, Cooper MT, Tan W, Wilding G, Henderson BW.

Lasers Surg Med. 2011 Sep;43(7):705-12. doi: 10.1002/lsm.21112.

4.

A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.

Yoo GH, Moon J, Leblanc M, Lonardo F, Urba S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J, Wolf G.

Arch Otolaryngol Head Neck Surg. 2009 Sep;135(9):869-74. doi: 10.1001/archoto.2009.122.

5.

Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.

Bellnier DA, Greco WR, Loewen GM, Nava H, Oseroff AR, Pandey RK, Tsuchida T, Dougherty TJ.

Cancer Res. 2003 Apr 15;63(8):1806-13.

6.

Photodynamic therapy and the treatment of head and neck neoplasia.

Biel MA.

Laryngoscope. 1998 Sep;108(9):1259-68. Review.

PMID:
9738739
8.

Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head and neck carcinomas.

Biel MA.

Arch Otolaryngol Head Neck Surg. 1996 Nov;122(11):1261-5.

PMID:
8906063
9.

Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck.

Kübler AC, Haase T, Staff C, Kahle B, Rheinwald M, Mühling J.

Lasers Surg Med. 1999;25(1):60-8.

PMID:
10421887
10.

Photodynamic therapy of head and neck cancers.

Biel MA.

Semin Surg Oncol. 1995 Sep-Oct;11(5):355-9.

PMID:
7569557
11.

Photodynamic therapy for head and neck dysplasia and cancer.

Rigual NR, Thankappan K, Cooper M, Sullivan MA, Dougherty T, Popat SR, Loree TR, Biel MA, Henderson B.

Arch Otolaryngol Head Neck Surg. 2009 Aug;135(8):784-8. doi: 10.1001/archoto.2009.98.

12.

Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.

Furukawa K, Yamamoto H, Crean DH, Kato H, Mang TS.

Lasers Surg Med. 1996;18(2):157-66.

PMID:
8833284
13.

[Photodynamic therapy for head and neck cancer].

Lajer CB, Specht LK, Kirkegaard J, Homøe P.

Ugeskr Laeger. 2006 Jun 5;168(23):2227-31. Review. Danish.

PMID:
16768973
14.

Intensification regimen 2 for advanced head and neck squamous cell carcinomas.

Grecula JC, Schuller DE, Rhoades CA, Au JL, Nag S, Bauer CJ, Agrawal A, Martinez-Monge R, Johnson A, Young D, Gahbauer RA.

Arch Otolaryngol Head Neck Surg. 1999 Dec;125(12):1313-8.

PMID:
10604408
15.
16.

2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy.

Lobel J, MacDonald IJ, Ciesielski MJ, Barone T, Potter WR, Pollina J, Plunkett RJ, Fenstermaker RA, Dougherty TJ.

Lasers Surg Med. 2001;29(5):397-405.

PMID:
11891727
17.

Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.

Mantovani G, Ghiani M, Lai P, Maccio A, Dessi D, Succu G, Massa D, Curreli L, Mulas C, Esu S, Proto E, Cadeddu G, Tore G.

Oncol Rep. 1998 Nov-Dec;5(6):1499-505.

PMID:
9769395
18.

Monitoring photobleaching and hemodynamic responses to HPPH-mediated photodynamic therapy of head and neck cancer: a case report.

Sunar U, Rohrbach D, Rigual N, Tracy E, Keymel K, Cooper MT, Baumann H, Henderson BH.

Opt Express. 2010 Jul 5;18(14):14969-78. doi: 10.1364/OE.18.014969.

19.

Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.

Wanebo HJ, Glicksman AS, Landman C, Slotman G, Doolittle C, Clark J, Koness RJ.

Am J Surg. 1995 Nov;170(5):512-6.

PMID:
7485745
20.

Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.

Ling SM, Roach M 3rd, Fu KK, Coleman C, Chan A, Singer M.

Cancer J Sci Am. 1996 Nov-Dec;2(6):321-9.

PMID:
9166552
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk